Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
life sciences & biomedicine (16) 16
science & technology (16) 16
middle aged (9) 9
oncology (9) 9
female (8) 8
adult (7) 7
breast cancer (7) 7
cancer (7) 7
chemotherapy (7) 7
medicine & public health (7) 7
aged (6) 6
cost-benefit analysis (6) 6
surgery (6) 6
aged, 80 and over (5) 5
biological and medical sciences (5) 5
medical sciences (5) 5
surgical oncology (5) 5
survival analysis (5) 5
breast neoplasms - mortality (4) 4
business & economics (4) 4
cost-effectiveness (4) 4
drug therapy (4) 4
economics (4) 4
filgrastim (4) 4
granulocyte colony-stimulating factor - economics (4) 4
granulocyte colony-stimulating factor - therapeutic use (4) 4
health care sciences & services (4) 4
health policy & services (4) 4
internal medicine (4) 4
social sciences (4) 4
united states (4) 4
abridged index medicus (3) 3
analysis (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
breast neoplasms - drug therapy (3) 3
health care costs (3) 3
health economics (3) 3
health policy (3) 3
mammography (3) 3
medical prognosis (3) 3
multivariate analysis (3) 3
neoplasm recurrence, local (3) 3
neoplasm staging (3) 3
neutropenia (3) 3
neutropenia - chemically induced (3) 3
neutropenia - prevention & control (3) 3
original research (3) 3
pegfilgrastim (3) 3
polyethylene glycols (3) 3
prevention (3) 3
public health, environmental and occupational health (3) 3
quality-adjusted life years (3) 3
recombinant proteins (3) 3
recurrence (3) 3
risk factors (3) 3
survival (3) 3
women (3) 3
anesthesia. intensive care medicine. transfusions. cell therapy and gene therapy (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
blood. blood and plasma substitutes. blood products. blood cells. blood typing. plasmapheresis. apheresis (2) 2
breast neoplasms - therapy (2) 2
cancer patients (2) 2
care and treatment (2) 2
cost-utility (2) 2
decision support techniques (2) 2
fever - chemically induced (2) 2
fever - economics (2) 2
fever - prevention & control (2) 2
florida (2) 2
general & internal medicine (2) 2
granulocyte colony-stimulating factor (2) 2
growth factors (2) 2
hematology (2) 2
macrophage colony stimulating factor (2) 2
melanoma - secondary (2) 2
metastases (2) 2
neoplasm recurrence, local - prevention & control (2) 2
neutropenia - economics (2) 2
pharmacology & pharmacy (2) 2
pharmacology. drug treatments (2) 2
practice guidelines as topic (2) 2
primary prophylaxis (2) 2
prognosis (2) 2
proportional hazards models (2) 2
prospective studies (2) 2
research (2) 2
sensitivity and specificity (2) 2
transfusions. complications. transfusion reactions. cell and gene therapy (2) 2
tumors (2) 2
united states - epidemiology (2) 2
african americans (1) 1
african continental ancestry group (1) 1
algorithms (1) 1
ambulatory care - economics (1) 1
amputation (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Multidisciplinary Care of Patients with Early-Stage Breast Cancer
by Lyman, Gary H and Baker, Jay and Geradts, Joseph and Horton, Janet and Kimmick, Gretchen and Peppercorn, Jeffrey and Pruitt, Scott and Scheri, Randall P and Hwang, E. Shelley
Surgical oncology clinics of North America, ISSN 1055-3207, 04/2013, Volume 22, Issue 2, pp. 299 - 317
Chemotherapy | Breast cancer | Mammography | Survivorship | Multidisciplinary | Oncology | Life Sciences & Biomedicine | Surgery | Science & Technology | Breast Neoplasms - therapy | Breast Neoplasms - pathology | Humans | Patient Care Team | Female | Clinical Trials as Topic | Combined Modality Therapy | Neoplasm Staging | Practice Guidelines as Topic
Journal Article
Details down arrow
2. Full Text Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the united states
by Lyman, Gary H., MD, MPH, FRCP and Lalla, Anjana, MS and Barron, Richard L., MS and Dubois, Robert W., MD, PhD
Clinical therapeutics, ISSN 0149-2918, 2009, Volume 31, Issue 5, pp. 1092 - 1104
Internal Medicine | Medical Education | filgrastim | cost-effectiveness | breast cancer | pegfilgrastim | primary prophylaxis | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Tumors | Severity of Illness Index | Polyethylene Glycols | Granulocyte Colony-Stimulating Factor - economics | United States | Humans | Middle Aged | Decision Support Techniques | Antineoplastic Agents - therapeutic use | Recombinant Proteins | Granulocyte Colony-Stimulating Factor - therapeutic use | Breast Neoplasms - drug therapy | Filgrastim | Antineoplastic Agents - adverse effects | Cost-Benefit Analysis | Neutropenia - prevention & control | Sensitivity and Specificity | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Neutropenia - chemically induced | Women | Chemotherapy | Granulocyte colony-stimulating factor | Analysis | Breast cancer | Macrophage colony stimulating factor | Drug therapy | Diseases | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients with T3, Stage II Colon Cancer: Impact on Quality-Adjusted Life Expectancy and Costs
by Hornberger, John, MD, MS and Lyman, Gary H., MD, MPH, FRCP(Edin) and Chien, Rebecca, BA and Meropol, Neal J., MD
Value in health, ISSN 1098-3015, 2012, Volume 15, Issue 8, pp. 1014 - 1021
Internal Medicine | cost-effectiveness | cancer | technological change | cost-utility | health economics | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Business & Economics | Health Policy & Services | Science & Technology | Quality-Adjusted Life Years | Markov Chains | Neoplasm Recurrence, Local - economics | Prognosis | Neoplasm Recurrence, Local - prevention & control | United States | Colonic Neoplasms - drug therapy | Humans | Colonic Neoplasms - diagnosis | Colonic Neoplasms - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Life Expectancy | Cost-Benefit Analysis | Antineoplastic Combined Chemotherapy Protocols - economics | Chemotherapy, Adjuvant - economics | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Preventing VTE in Outpatients With Cancer
by Khorana, Alok A., MD and Spyropoulos, Alex C., MD, FCCP and Zwicker, Jeffrey, MD and Lyman, Gary H., MD, MPH and Francis, Charles W., MD
Chest, ISSN 0012-3692, 2012, Volume 142, Issue 1, pp. 265 - 266
Pulmonary/Respiratory | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Fibrinolytic Agents - adverse effects | Venous Thromboembolism - prevention & control | Societies, Medical | Fibrinolytic Agents - therapeutic use | Humans | Evidence-Based Medicine | Venous Thromboembolism - drug therapy | Prevention | Cancer patients | Care and treatment | Venous thrombosis | Demographic aspects | Index Medicus | Abridged Index Medicus | Correspondence
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Cost-Effectiveness of Primary versus Secondary Prophylaxis with Pegfilgrastim in Women with Early-Stage Breast Cancer Receiving Chemotherapy
by Ramsey, Scott D., MD, PhD and Liu, Zhimei, PhD and Boer, Rob, PhD and Sullivan, Sean D., PhD and Malin, Jennifer, MD, PhD and Doan, Quan V., PharmD and Dubois, Robert W., MD, PhD and Lyman, Gary H., MD, MPH, FRCP (Edin)
Value in health, ISSN 1098-3015, 2009, Volume 12, Issue 2, pp. 217 - 225
Internal Medicine | cost-effectiveness | breast cancer | pegfilgrastim | primary prophylaxis | cost‐effectiveness | Primary prophylaxis | Pegfilgrastim | Breast cancer | Cost-effectiveness | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Business & Economics | Health Policy & Services | Science & Technology | Breast Neoplasms - economics | Granulocyte Colony-Stimulating Factor - economics | United States | Humans | Middle Aged | Risk | Recombinant Proteins | Fever - chemically induced | Filgrastim | Fever - economics | Antineoplastic Agents - adverse effects | Neutropenia - mortality | Aged, 80 and over | Adult | Female | Neutropenia - chemically induced | Decision Making | Quality-Adjusted Life Years | Primary Prevention - economics | Polyethylene Glycols | Risk Assessment | Risk Reduction Behavior | Risk Factors | Decision Support Techniques | Probability | Neutropenia - economics | Granulocyte Colony-Stimulating Factor - therapeutic use | Breast Neoplasms - drug therapy | Health Care Costs | Secondary Prevention - economics | Cost-Benefit Analysis | Neutropenia - prevention & control | Breast Neoplasms - mortality | Fever - prevention & control | Aged | Women | Oncology, Experimental | Health insurance industry | Research | Peptide hormones | Prevention | Chemotherapy | Granulocyte colony-stimulating factor | Analysis | Macrophage colony stimulating factor | Universities and colleges | Growth factors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Economic Analysis of Prophylactic Pegfilgrastim in Adult Cancer Patients Receiving Chemotherapy
by Eldar-Lissai, Adi, MBA and Cosler, Leon E., RPh, PhD and Culakova, Eva, PhD and Lyman, Gary H., MD, MPH, FRCP (Edin)
Value in health, ISSN 1098-3015, 2008, Volume 11, Issue 2, pp. 172 - 179
Internal Medicine | granulocyte colony-stimulating factors | neutropenia | cancer | febrile neutropenia | decision models | cost analysis | granulocyte colony‐stimulating factors | Decision models | Granulocyte colony-stimulating factors | Cost analysis | Cancer | Febrile neutropenia | Neutropenia | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Business & Economics | Health Policy & Services | Science & Technology | Quality-Adjusted Life Years | Meta-Analysis as Topic | Polyethylene Glycols | Granulocyte Colony-Stimulating Factor - economics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Models, Economic | Recombinant Proteins | Granulocyte Colony-Stimulating Factor - therapeutic use | Filgrastim | Neutropenia - drug therapy | Randomized Controlled Trials as Topic | Neutropenia - complications | Algorithms | Colony-Stimulating Factors - economics | Cost-Benefit Analysis | Adult | Aged | Ambulatory Care - economics | Colony-Stimulating Factors - therapeutic use | Hospitalization - economics | Monte Carlo method | Chemotherapy | Cancer patients | Analysis | Models | Social aspects | Drug therapy | Medical economics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efficacy and Cost-effectiveness of the Children’s Oncology Group Long-Term Follow-Up Screening Guidelines for Childhood Cancer Survivors at Risk of Treatment-related Heart Failure
by Wong, F. Lennie and Bhatia, Smita and Landier, Wendy and Francisco, Liton and Leisenring, Wendy and Hudson, Melissa M and Armstrong, Gregory T and Mertens, Ann and Stovall, Marilyn and Robison, Leslie L and Lyman, Gary H and Lipshultz, Steven E and Armenian, Saro H
Annals of internal medicine, ISSN 0003-4819, 5/2014, Volume 160, Issue 10, pp. 672 - 683
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Commentary: Chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines
by Lyman, By Gary H
Journal of oncology practice, ISSN 1554-7477, 01/2011, Volume 7, Issue 1, pp. 17 - 18
Journal Article
Details down arrow
9. Preventing venous thromboembolism in cancer patients: Can we do better?
by Lyman, Gary H
Journal of oncology practice, ISSN 1554-7477, 07/2009, Volume 5, Issue 4, pp. 165 - 166
Journal Article
Details down arrow
10. Undertreatment of cancer patients with chemotherapy is a global concern
by Lyman, Gary H
Journal of oncology practice, ISSN 1554-7477, 05/2008, Volume 4, Issue 3, pp. 114 - 115
Journal Article
Details down arrow
11. Caring for the elderly cancer patient: Training the next generation of oncologists
by Lyman, Gary H
Journal of oncology practice, ISSN 1554-7477, 2008, Volume 4, Issue 4, pp. 193 - 194
Journal Article
Details down arrow
12. ASCO clinical practice guidelines: Past, present and future
by Lyman, Gary H
Journal of oncology practice, ISSN 1554-7477, 2008, Volume 4, Issue 5, pp. 236 - 237
Journal Article
Details down arrow
13. Editorial: Gene expression profile assays as an aid in treatment decision making in early-stage breast cancer
by Lyman, Gary H
Journal of oncology practice, ISSN 1554-7477, 07/2007, Volume 3, Issue 4, pp. 187 - 188
Journal Article
Details down arrow
14. Full Text Patients' attitudes regarding out‐of‐hospital blood transfusion
by Benson, K and Balducci, L and Milo, K. M and Heckel, L and Lyman, G. H
Transfusion (Philadelphia, Pa.), ISSN 0041-1132, 02/1996, Volume 36, Issue 2, pp. 140 - 143
Life Sciences & Biomedicine | Hematology | Science & Technology | Biological and medical sciences | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Blood Transfusion | Home Care Agencies | Attitude | Humans | Middle Aged | Aged, 80 and over | Adult | Aged | Florida | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Cost‐effectiveness of white cell‐reduction filters in treatment of adult acute myelogenous leukemia
by Balducci, L and Benson, K and Lyman, G.H and Sanderson, R and Fields, K and Ballester, O.F and Elfenbein, G.J
Transfusion (Philadelphia, Pa.), ISSN 0041-1132, 08/1993, Volume 33, Issue 8, pp. 665 - 670
Life Sciences & Biomedicine | Hematology | Science & Technology | Biological and medical sciences | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Blood Component Transfusion | Leukocyte Count - economics | Immunization | Isoantibodies - administration & dosage | Cost-Benefit Analysis | Humans | Isoantibodies - immunology | Leukemia, Myeloid, Acute - surgery | Filtration - methods | Leukocyte Count - methods | Filtration - instrumentation | Leukocytes - cytology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Pharmacoeconomics of the Myeloid Growth Factors
: A Critical and Systematic Review
by Hirsch, Bradford R and Lyman, Gary H
PharmacoEconomics, ISSN 1170-7690, 6/2012, Volume 30, Issue 6, pp. 497 - 511
Quality of Life Research | Health Economics | Health Administration | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | Healthcare-expenditure | Pegfilgrastim | Febrile-neutropenia | Granulocyte-colony-stimulating-factors | Cost-effectiveness | Cost-utility | Filgrastim | Neutropenia | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Pharmacology & Pharmacy | Business & Economics | Health Policy & Services | Science & Technology | Toxicity: blood | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Drug toxicity and drugs side effects treatment | Miscellaneous (drug allergy, mutagens, teratogens...) | Immunomodulators | Drug Costs | Economics, Pharmaceutical | Biosimilar Pharmaceuticals - therapeutic use | Granulocyte Colony-Stimulating Factor - economics | United States | Europe | Humans | Antineoplastic Agents - therapeutic use | Biosimilar Pharmaceuticals - economics | Neutropenia - economics | Granulocyte Colony-Stimulating Factor - therapeutic use | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Fever - chemically induced | Neoplasms - drug therapy | Fever - economics | Antineoplastic Agents - adverse effects | Cost-Benefit Analysis | Neutropenia - prevention & control | Fever - prevention & control | Neutropenia - chemically induced | Granulocyte-Macrophage Colony-Stimulating Factor - economics | Cost-effectiveness; Cost-utility; Febrile-neutropenia; Filgrastim; Granulocyte-colony-stimulating-factors; Healthcare-expenditure; Neutropenia; Pegfilgrastim. | Prevention | Usage | Economic aspects | Research | Growth factors | Medical care, Cost of | Cancer
Journal Article